Tae Hyung Kim

发表

Doxorubicin-loaded highly porous large PLGA microparticles as a sustained- release inhalation system for the treatment of metastatic lung cancer.

Insoo Kim, Beom Soo Shin, Eun Seong Lee, 2012, Biomaterials.

Nanotheranostics for personalized medicine

Xiaoyuan Chen, Seulki Lee, Seulki Lee, 2013, Expert review of molecular diagnostics.

Delivery of tumor-homing TRAIL sensitizer with long-acting TRAIL as a therapy for TRAIL-resistant tumors.

M. Pomper, Kwangmeyung Kim, M. Swierczewska, 2015, Journal of controlled release : official journal of the Controlled Release Society.

Evaluation of interstitial protein delivery in multicellular layers model

Soo-Yeon Kim, K. Park, H. Kuh, 2012, Archives of Pharmacal Research.

Doxorubicin-loaded human serum albumin nanoparticles surface-modified with TNF-related apoptosis-inducing ligand and transferrin for targeting multiple tumor types.

Eun Seong Lee, Y. Youn, K. Oh, 2012, Biomaterials.

PEGylated TNF-related apoptosis-inducing ligand (TRAIL)-loaded sustained release PLGA microspheres for enhanced stability and antitumor activity.

Xiaoyuan Chen, Seulki Lee, Y. Youn, 2011, Journal of controlled release : official journal of the Controlled Release Society.

Improved Antitumor Activity and Tumor Targeting of NH2-Terminal–Specific PEGylated Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand

Kwangmeyung Kim, I. Kwon, D. Jo, 2010, Molecular Cancer Therapeutics.

Apoptotic activity and antitumor efficacy of PEGylated TNF-related apoptosis-inducing ligand (TRAIL) in a Mia Paca-2 cell-xenografted mouse model.

Seong Ho Choi, Eun Seong Lee, Y. Youn, 2014, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Preparation and characterization of water-soluble albumin-bound curcumin nanoparticles with improved antitumor activity.

Xiaoyuan Chen, Seulki Lee, Y. Youn, 2011, International journal of pharmaceutics.

Improved biological half-life and anti-tumor activity of TNF-related apoptosis-inducing ligand (TRAIL) using PEG-exposed nanoparticles.

Xiaoyuan Chen, Seulki Lee, Kang-Choon Lee, 2011, Biomaterials.

Site-specific PEGylated Exendin-4 modified with a high molecular weight trimeric PEG reduces steric hindrance and increases type 2 antidiabetic therapeutic effects.

Y. Byun, K. Choi, Xiaoyuan Chen, 2012, Bioconjugate chemistry.

PEGylated TNF-related apoptosis-inducing ligand (TRAIL) for effective tumor combination therapy.

Xiaoyuan Chen, Seulki Lee, Y. Youn, 2011, Biomaterials.

Doxorubicin-loaded porous PLGA microparticles with surface attached TRAIL for the inhalation treatment of metastatic lung cancer.

Eun Seong Lee, B. Shin, Y. Youn, 2013, Biomaterials.

Albumin-Coated Porous Hollow Poly(Lactic-co-Glycolic Acid) Microparticles Bound with Palmityl-Acylated Exendin-4 as a Long-Acting Inhalation Delivery System for the Treatment of Diabetes

Eun Seong Lee, Y. Bae, Hyunuk Kim, 2011, Pharmaceutical Research.

Highly porous large poly(lactic-co-glycolic acid) microspheres adsorbed with palmityl-acylated exendin-4 as a long-acting inhalation system for treating diabetes.

Eun Seong Lee, Hyunuk Kim, Y. Youn, 2011, Biomaterials.

Biochemical, pharmaceutical and therapeutic properties of long-acting lithocholic acid derivatized exendin-4 analogs.

Y. Byun, Myung-Shik Lee, S. Chae, 2010, Journal of controlled release : official journal of the Controlled Release Society.

Hyaluronic acid-tumor necrosis factor-related apoptosis-inducing ligand conjugate for targeted treatment of liver fibrosis.

S. Hahn, W. Kong, Kang-Choon Lee, 2015, Acta biomaterialia.

Low molecular weight (1 kDa) polyethylene glycol conjugation markedly enhances the hypoglycemic effects of intranasally administered exendin-4 in type 2 diabetic db/db mice.

Y. Youn, Kang-Choon Lee, S. Lim, 2012, Biological & pharmaceutical bulletin.

Mono-PEGylated dimeric exendin-4 as high receptor binding and long-acting conjugates for type 2 anti-diabetes therapeutics.

Y. Byun, Xiaoyuan Chen, Seulki Lee, 2011, Bioconjugate chemistry.

Effect of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand on the Reduction of Joint Inflammation in Experimental Rheumatoid Arthritis

E. Lee, Yeong-Wook Song, D. Jo, 2010, Journal of Pharmacology and Experimental Therapeutics.

Pulmonary administered palmitic-acid modified exendin-4 peptide prolongs hypoglycemia in type 2 diabetic db/db mice

Eun Seong Lee, H. Moon, S. Chi, 2012, Regulatory Peptides.

Preparation and characterization of Apo2L/TNF-related apoptosis-inducing ligand-loaded human serum albumin nanoparticles with improved stability and tumor distribution.

Y. Youn, Kang-Choon Lee, S. Lim, 2011, Journal of pharmaceutical sciences.

Self-assembled glycol chitosan nanogels containing palmityl-acylated exendin-4 peptide as a long-acting anti-diabetic inhalation system.

Eun Seong Lee, B. Shin, S. Chi, 2012, Journal of controlled release : official journal of the Controlled Release Society.

Mix to validate: a facile, reversible PEGylation for fast screening of potential therapeutic proteins in vivo.

M. Pomper, Y. Byun, D. Jo, 2013, Angewandte Chemie.

Smad7 Protein Induces Interferon Regulatory Factor 1-dependent Transcriptional Activation of Caspase 8 to Restore Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL)-mediated Apoptosis

Seong-Jin Kim, Kang-Choon Lee, Tae Hyung Kim, 2012, The Journal of Biological Chemistry.

A new orally available glucagon-like peptide-1 receptor agonist, biotinylated exendin-4, displays improved hypoglycemic effects in db/db mice.

S. Chae, Sohee Son, Y. Youn, 2009, Journal of controlled release : official journal of the Controlled Release Society.

Preparation and evaluation of palmitic acid-conjugated exendin-4 with delayed absorption and prolonged circulation for longer hypoglycemia.

Eun Seong Lee, H. Moon, Y. Youn, 2012, International journal of pharmaceutics.

PEG-transferrin conjugated TRAIL (TNF-related apoptosis-inducing ligand) for therapeutic tumor targeting.

Y. Byun, Xiaoyuan Chen, Seulki Lee, 2012, Journal of controlled release : official journal of the Controlled Release Society.

PEGylated TNF-related apoptosis-inducing ligand (TRAIL) analogues: pharmacokinetics and antitumor effects.

Xiaoyuan Chen, Seulki Lee, Y. Youn, 2011, Bioconjugate chemistry.

Intrapulmonary potential of polyethylene glycol-modified glucagon-like peptide-1s as a type 2 anti-diabetic agent

Eun Seong Lee, S. Chae, Seulki Lee, 2009, Regulatory Peptides.

Evaluation of interstitial protein delivery in multicellular layers model

H. Kuh, Kang-Choon Lee, Tae Hyung Kim, 2012, Archives of Pharmacal Research.

Systemic PEGylated TRAIL treatment ameliorates liver cirrhosis in rats by eliminating activated hepatic stellate cells

M. Pomper, Kwangmeyung Kim, Y. Byun, 2016, Hepatology.

Synthesis and evaluation of human serum albumin-modified exendin-4 conjugate via heterobifunctional polyethylene glycol linkage with protracted hypoglycemic efficacy.

Eun Seong Lee, Y. Youn, K. Oh, 2010, Bioconjugate chemistry.

Biological and physicochemical evaluation of the conformational stability of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)

S. Chae, Y. Youn, Kang-Choon Lee, 2007, Biotechnology Letters.

Systemic PEGylated TRAIL treatment ameliorates liver cirrhosis in rats by eliminating activated hepatic stellate cells

M. Pomper, Kwangmeyung Kim, Y. Byun, 2016, Hepatology.

Preparation and characterization of water-soluble albumin-bound curcumin nanoparticles with improved antitumor activity.

Xiaoyuan Chen, Seulki Lee, Y. Youn, 2011, International journal of pharmaceutics.

A 4-arm polyethylene glycol derivative conjugated with exendin-4 peptide and palmitylamine having dual-function of size-increase and albumin-binding for long hypoglycemic action

Eun Seong Lee, Y. Youn, K. Oh, 2011, Regulatory Peptides.

Effect of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand on the Reduction of Joint Inflammation in Experimental Rheumatoid Arthritis

E. Lee, D. Jo, S. Chae, 2010, Journal of Pharmacology and Experimental Therapeutics.

Decanoic acid-modified glycol chitosan hydrogels containing tightly adsorbed palmityl-acylated exendin-4 as a long-acting sustained-release anti-diabetic system.

Eun Seong Lee, Y. Youn, K. Oh, 2014, Acta biomaterialia.